Eli Lilly & Co. closed $63.38 below its 52-week high ($972.53), which the company reached on August 22nd.

Whittier Trust Co. of Nevada Inc. boosted its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 7.4% during the ...

A group of U.S. senators are digging into the direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer this ...

Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily ...

James Hambro & Partners LLP boosted its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 3.7% in the third ...

Monday’s lawsuits from Eli Lilly are the first to be filed by the pharma since the regulator officially removed tirzepatide ...

The New York Times looks at why hospital gowns are so unflattering. In Washington state, four agricultural workers tested ...

Bernstein has recently initiated Eli Lilly And Co (LLY) stock to Outperform rating, as announced on October 17, 2024, according to Finviz. Earlier, on September 13, 2024, Citigroup had resumed the ...

Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.

MangoRx remains committed to its mission and plans to continue to enhance patient care by offering new and innovative solutions while striving to comply with federal, state and local regulatory ...

Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.